Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Improving Access for Pharmacists to Appropriate Drug Interaction and Dosing Data with Virginia Halsey First Databank TRANSCRIPT
Download PDFDec 16, 2022
Virginia Halsey, Vice President of Product Management at FDB, First Databank, is focused on helping pharmacists use drug interaction information, drug alerts and dosage data in smarter, more efficient ways. WIth patient safety in mind, FDB is arming pharmacists with relevant content to determine the clinical impact of a specific drug on a specific patient.
Virginia elaborates, "First Databank is drug content, but a very specific niche of drug content in that it is structured in such a way that it's built into the workflow of other systems. So, for instance, if a patient goes into a retail pharmacy, the pharmacist behind the counter is using their system to basically fill the prescription, adjudicate the claim, and so forth. But that drug content that's within their system comes from First Databank. Content that describes the products that are available, the pricing, and most importantly, clinical information about the drug, such as what's the appropriate dose or what are the drug interactions."
"It's saving time, and it's addressing cognitive overload. So yes, the pharmacist can read this list of potential safety issues and interpret it, but there are a couple of problems. One is that then you have to take that time to sort through and think about the alternatives, maybe look something up. The other is, then, you get a lack of standardization because one pharmacist may come to one conclusion. Another may come to another conclusion instead of having standardized practice protocols and alternatives."
@FDB_US #FirstDatabank #Pharmacy #Healthtech #Pharmacists #MedicationGuidance #HIT
